HAKA: Routine Follow-Up at 1 Year After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorJointResearch

About this trial

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up.

The HAKA trial consists of three different work packages (WPs). This trial (WP1) investigates the 1-year follow-up, WP2 examines the 10-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.

Eligibility criteria

Qualifiers

Painful and disabled hip or knee joint resulting from osteoarthritis

Scheduled for primary THA or TKA surgery

Age 50 years or older at the time of THA or TKA

Capable and willing to complete questionnaires

Disqualifiers

Other indication for surgery than osteoarthritis

Scheduled for hip or knee revision arthroplasty, except a conversion from unicompartmental knee arthroplasty to TKA or from hip hemiarthroplasty/resurfacing to THA

Already participating in this study due to a previous hip or knee surgery

Trial design

Treatments tested in this trial

  • Routine Follow-Up (RFU)
  • Check-Up on Demand (COD)

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

JointResearch

Lead sponsor

Reinier Haga Orthopedisch Centrum

Collaborator

Tergooi MC

Collaborator